GB0108475D0 - New compounds - Google Patents

New compounds

Info

Publication number
GB0108475D0
GB0108475D0 GBGB0108475.5A GB0108475A GB0108475D0 GB 0108475 D0 GB0108475 D0 GB 0108475D0 GB 0108475 A GB0108475 A GB 0108475A GB 0108475 D0 GB0108475 D0 GB 0108475D0
Authority
GB
United Kingdom
Prior art keywords
new compounds
compounds
new
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB0108475.5A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Organon Pharma UK Ltd
Original Assignee
Merck Sharp and Dohme Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Sharp and Dohme Ltd filed Critical Merck Sharp and Dohme Ltd
Priority to GBGB0108475.5A priority Critical patent/GB0108475D0/en
Publication of GB0108475D0 publication Critical patent/GB0108475D0/en
Priority to PCT/GB2002/001502 priority patent/WO2002081474A1/en
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
GBGB0108475.5A 2001-04-04 2001-04-04 New compounds Ceased GB0108475D0 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
GBGB0108475.5A GB0108475D0 (en) 2001-04-04 2001-04-04 New compounds
PCT/GB2002/001502 WO2002081474A1 (en) 2001-04-04 2002-03-28 Triazolophthalazine / quinoline / isoquinoline derivatives which are ligands for gaba-a receptors containing the alpha 5 subtype

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0108475.5A GB0108475D0 (en) 2001-04-04 2001-04-04 New compounds

Publications (1)

Publication Number Publication Date
GB0108475D0 true GB0108475D0 (en) 2001-05-23

Family

ID=9912253

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB0108475.5A Ceased GB0108475D0 (en) 2001-04-04 2001-04-04 New compounds

Country Status (2)

Country Link
GB (1) GB0108475D0 (en)
WO (1) WO2002081474A1 (en)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EA014324B1 (en) * 2004-09-02 2010-10-29 Никомед Гмбх Triazolophthalazines
GB0420970D0 (en) * 2004-09-21 2004-10-20 Smithkline Beecham Corp Novel triazoloquinoline compounds
KR101022082B1 (en) 2005-10-11 2011-03-17 에프. 호프만-라 로슈 아게 Isoxazole derivatives
KR101121240B1 (en) 2005-12-23 2012-06-12 에프. 호프만-라 로슈 아게 Aryl-isoxazolo-4-yl-oxadiazole derivatives
RU2425045C2 (en) 2005-12-27 2011-07-27 Ф. Хоффманн-Ля Рош Аг Aryl-isoxazole-4-yl-imidazole derivatives
BRPI0706560A2 (en) 2006-01-17 2011-03-29 Hoffmann La Roche aryl-isoxazol-4-yl-imidazo [1,2-a] pyridine derivatives useful for the treatment of alzheimer's disease via gaba receptors
JP5087616B2 (en) 2006-05-31 2012-12-05 エフ．ホフマン−ラ ロシュ アーゲー Aryl-4-ethynyl-isoxazole derivatives
HUP0700395A2 (en) 2007-06-07 2009-03-02 Sanofi Aventis Substituted [1,2,4] triazolo [1,5-a] quinolines, process for their preparation, pharmaceutical compositions thereof, and intermediates
WO2008154447A1 (en) * 2007-06-08 2008-12-18 Helicon Therapeutics, Inc. Therapeutic pyrazolonaphthyridine derivatives
MX2009013202A (en) * 2007-06-08 2010-04-09 Helicon Therapeutics Inc Therapeutic pyrazoloquinoline derivatives.
AU2008267894B2 (en) 2007-06-22 2012-08-23 F. Hoffmann-La Roche Ag Isoxazole-imidazole derivatives
MX2010005753A (en) 2007-12-04 2010-06-15 Hoffmann La Roche Isoxazolo-pyrazine derivatives.
US7943619B2 (en) 2007-12-04 2011-05-17 Hoffmann-La Roche Inc. Isoxazolo-pyridazine derivatives
US7902201B2 (en) 2007-12-04 2011-03-08 Hoffmann-La Roche Inc. Isoxazolo-pyrazine derivatives
TW201033201A (en) 2009-02-19 2010-09-16 Hoffmann La Roche Isoxazole-isoxazole and isoxazole-isothiazole derivatives
US8389550B2 (en) 2009-02-25 2013-03-05 Hoffmann-La Roche Inc. Isoxazoles / O-pyridines with ethyl and ethenyl linker
US8222246B2 (en) 2009-04-02 2012-07-17 Hoffmann-La Roche Inc. Substituted isoxazoles
US20100280019A1 (en) 2009-04-30 2010-11-04 Roland Jakob-Roetne Isoxazoles
KR101701533B1 (en) 2009-05-05 2017-02-13 에프. 호프만-라 로슈 아게 Isoxazole-pyridazine derivatives
CA2760166C (en) 2009-05-05 2017-07-18 F. Hoffmann-La Roche Ag Isoxazole-pyridine derivatives
BRPI1011729A2 (en) 2009-05-05 2016-03-15 Hoffmann La Roche isoxazole-thiazole derivatives as an inverse receptor boasts agonist for use in the treatment of cognitive disorders
CN102414205B (en) 2009-05-05 2014-11-05 弗·哈夫曼-拉罗切有限公司 Isoxazole-pyrazole derivatives
MX2011011484A (en) 2009-05-07 2011-11-18 Hoffmann La Roche Isoxazole-pyridine derivatives as gaba modulators.
KR101925158B1 (en) * 2010-08-02 2018-12-04 가부시키가이샤 한도오따이 에네루기 켄큐쇼 Triazole derivative, heterocyclic compound, light-emitting element, light-emitting device, electronic device and lighting device
US8785435B2 (en) 2011-10-20 2014-07-22 Hoffmann-La Roche Inc. Solid forms
US20150374705A1 (en) 2012-02-14 2015-12-31 Shanghai Institues for Biological Sciences Substances for treatment or relief of pain
KR101640637B1 (en) * 2012-05-31 2016-07-18 주식회사 엘지화학 New heterocyclic compounds, production process thereof and organic electronic device using the same

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ333768A (en) * 1996-07-25 2000-09-29 Merck Sharp & Dohme Substituted triazolo-pyridazine derivatives as ligands for GABA receptors
CA2288789C (en) * 1997-05-08 2009-07-21 Merck Sharp & Dohme Limited Substituted 1,2,4-triazolo[3,4-a]phthalazine derivatives as gaba alpha 5 ligands
GB9929569D0 (en) * 1999-12-14 2000-02-09 Merck Sharp & Dohme Therapeutic agents
GB0017518D0 (en) * 2000-07-17 2000-08-30 Merck Sharp & Dohme Therapeutic agents

Also Published As

Publication number Publication date
WO2002081474A1 (en) 2002-10-17

Similar Documents

Publication Publication Date Title
AU2002349297A8 (en) Statin-like compounds
GB0126433D0 (en) Compounds
GB0101996D0 (en) Organtic compounds
GB0112324D0 (en) Compounds
GB0102668D0 (en) Compounds
GB0108475D0 (en) New compounds
GB0108102D0 (en) Compounds
GB0119474D0 (en) Compounds
GB0102673D0 (en) Compounds
GB0102665D0 (en) Compounds
GB0119472D0 (en) Compounds
EP1458669A4 (en) Neuorologically-active compounds
GB0115178D0 (en) Compounds
GB0118364D0 (en) Compounds
GB0108097D0 (en) Compounds
GB0119473D0 (en) Compounds
GB0105098D0 (en) Compounds
HUP0102279D0 (en) New compounds
GB0117780D0 (en) New compounds
GB0120324D0 (en) Compounds
GB0116781D0 (en) Compounds
GB0101628D0 (en) Compounds
GB0103314D0 (en) Compounds
GB0125121D0 (en) Compounds
GB0100652D0 (en) Polysulfamated compounds

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)